HIT (Health In Tech, Inc. Class A Common Stock) Stock Analysis - SEC Filings

Health In Tech, Inc. Class A Common Stock (HIT) is a publicly traded Technology sector company. As of May 21, 2026, HIT trades at $0.97 with a market cap of $68.81M and a P/E ratio of -50.95. HIT moved +2.97% today. Year to date, HIT is -40.24%; over the trailing twelve months it is +54.22%. Its 52-week range spans $0.51 to $7.59. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces HIT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find HIT SEC filings?

Rallies organizes HIT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

HIT Key Metrics

Key financial metrics for HIT
MetricValue
Price$0.97
Market Cap$68.81M
P/E Ratio-50.95
EPS$-0.02
Dividend Yield0.38%
52-Week High$7.59
52-Week Low$0.51
Volume671
Avg Volume0
Revenue (TTM)$34.08M
Net Income$-808.03K
Gross Margin58.95%

Latest HIT News

HIT Analyst Consensus

2 analysts cover HIT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.

Common questions about HIT

Where can I find HIT SEC filings?
Rallies organizes HIT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show HIT 10-K and 10-Q filings?
Rallies organizes HIT SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is HIT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HIT. It does not provide personalized investment advice.
HIT

HIT